Full Archive

Nothing new here

There are times we sit back and wonder what all the fuss is about. We’ve been having these moments a lot lately especially in the digital/virtual health market. And not to get off track should we not come up with a new term that encompasses digital/virtual into one phrase perhaps maybe disease management with new technology or is that too old school. But things are pretty much playing out as...

A sign of things to come?

Before we get into business a little shameless self-promotion but self-promotion for some very worthy organizations. Some of you are aware of my past efforts at raising money while doing a triathlon. This year given I haven’t been able to race because of Covid I decided to do something a little different. First I am raising money for THREE charities – Beyond Type 1 – Homeless Veterans in San Diego...

The Rules

Ok we’re getting just a little irked at all these CGM, OmniPod and Tyler wannabes. So in an effort to separate the real from the imagined we have created some rules for these companies. See we get lots of inquiries from these start up toy companies most of whom that don’t stand an ice cubes chance in hell of ever becoming a commercially viable toy company. Yet each one has...

What matters, what doesn’t

When it comes to the toys in the toy chest there is no better conference than ATTD and while virtual this year once again the diabetes device world is going gaga this week. Dexcom revealed more details about the G7, Medtronic released more data on hybrid closed loop and Senseonics data on their longer term sensor. As valuable as this information may be the question is does it matter all...

The Ultimate Toy

In case anyone hasn’t noticed there is a virtual toy fair going on this week with ATTD. Yes lots of data, lots of way cool whiz bang lots of pontificating and in the end nothing much really changes all that much. That is unless you’re the CEO of the most innovative toy in diabetes history which is why we are so pleased to release another Wacky World of Diabetes podcast...

Does it matter?

One day someone will have to explain to us how a company that once dominated a market only to screw it up because of their own arrogance should be given the benefit of the doubt. This is basically what Medtronic is asking investors to do when it comes to their still struggling diabetes unit. They want to be given yet another chance as this is not the first not even...

a

News, notes and other things

While the FDA continues to deal with the backlog created by Covid things in Europe seem to be moving a bit quicker. Today Medtronic announced they have obtained CE marks for their Guardian 4 sensor plus expanded functionality for their InPen system. Per a company issued press release; “Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced CE (Conformité Européenne) Mark for expanded functionality of the company's InPen™ smart2...